ANC 0 3 0 3 B-clinical_variable
≥ 4 5 4 5 O
1,500 6 11 6 11 B-lower_bound
/ 11 12 11 12 I-lower_bound
ul 12 14 12 14 I-lower_bound

Active 0 6 15 21 B-chronic_disease
infection 7 16 22 31 I-chronic_disease
requiring 17 26 32 41 O
therapy 27 34 42 49 B-treatment

Adequacy 0 8 50 58 O
of 9 11 59 61 O
collected 12 21 62 71 O
material 22 30 72 80 O
will 31 35 81 85 O
be 36 38 86 88 O
determined 39 49 89 99 O
within 50 56 100 106 O
5 57 58 107 108 B-upper_bound
business 59 67 109 117 I-upper_bound
days 68 72 118 122 I-upper_bound
of 73 75 123 125 O
each 76 80 126 130 O
collected 81 90 131 140 O
case 91 95 141 145 O

Adequate 0 8 146 154 O
hematologic 9 20 155 166 O
, 20 21 166 167 O
renal 22 27 168 173 O
, 27 28 173 174 O
and/or 29 35 175 181 O
hepatic 36 43 182 189 O
function 44 52 190 198 O
( 53 54 199 200 O
following 54 63 200 209 O
criteria 64 72 210 218 O
must 73 77 219 223 O
be 78 80 224 226 O
met 81 84 227 230 O
within 85 91 231 237 O
28 92 94 238 240 B-upper_bound
days 95 99 241 245 I-upper_bound
of 100 102 246 248 O
C1D1 103 107 249 253 O

Adrenal 0 7 254 261 B-treatment
replacement 8 19 262 273 I-treatment
doses 20 25 274 279 O
are 26 29 280 283 O
permitted 30 39 284 293 O
in 40 42 294 296 O
the 43 46 297 300 O
absence 47 54 301 308 O
of 55 57 309 311 O
active 58 64 312 318 O
autoimmune 65 75 319 329 B-chronic_disease
disease 76 83 330 337 I-chronic_disease

Advanced 0 8 338 346 O
stage 9 14 347 352 O
NSCLC 15 20 353 358 B-cancer

All 0 3 359 362 O
patients 4 12 363 371 O
with 13 17 372 376 O
adenocarcinoma 18 32 377 391 B-cancer
histology 33 42 392 401 O
must 43 47 402 406 O
be 48 50 407 409 O
tested 51 57 410 416 O
for 58 61 417 420 O
EGFR 62 66 421 425 O
and 67 70 426 429 O
ALK 71 74 430 433 O
status 75 81 434 440 O

Any 0 3 441 444 O
positive 4 12 445 453 O
test 13 17 454 458 O
for 18 21 459 462 O
HCV 22 25 463 466 B-chronic_disease
RNA 26 29 467 470 B-chronic_disease
or 30 32 471 473 O
HBsAg 33 38 474 479 B-chronic_disease

Any 0 3 480 483 O
positive 4 12 484 492 O
test 13 17 493 497 O
for 18 21 498 501 O
HIV 22 25 502 505 B-chronic_disease

Any 0 3 506 509 O
systemic 4 12 510 518 O
anti 13 17 519 523 B-treatment
- 17 18 523 524 I-treatment
cancer 18 24 524 530 I-treatment
therapy 25 32 531 538 I-treatment
within 33 39 539 545 O
3 40 41 546 547 B-upper_bound
weeks 42 47 548 553 I-upper_bound
prior 48 53 554 559 I-upper_bound
to 54 56 560 562 O
C1D1 57 61 563 567 O
of 62 64 568 570 O
study 65 70 571 576 O
therapy 71 78 577 584 O

Be 0 2 585 587 O
scheduled 3 12 588 597 O
to 13 15 598 600 O
undergo 16 23 601 608 O
a 24 25 609 610 O
standard 26 34 611 619 B-treatment
- 34 35 619 620 I-treatment
of 35 37 620 622 I-treatment
- 37 38 622 623 I-treatment
care 38 42 623 627 I-treatment
resection 43 52 628 637 I-treatment
of 53 55 638 640 O
tumor 56 61 641 646 B-cancer
tissue 62 68 647 653 I-cancer
as 69 71 654 656 O
part 72 76 657 661 O
of 77 79 662 664 O
treatment 80 89 665 674 B-treatment
plan 90 94 675 679 O
prior 95 100 680 685 O
to 101 103 686 688 O
beginning 104 113 689 698 O
study 114 119 699 704 O
therapy 120 127 705 712 B-treatment

ECOG 0 4 713 717 B-clinical_variable
performance 5 16 718 729 I-clinical_variable
status 17 23 730 736 I-clinical_variable
of 24 26 737 739 O
0 27 28 740 741 B-lower_bound
- 28 29 741 742 O
1 29 30 742 743 B-upper_bound

Exception 0 9 744 753 O
is 10 12 754 756 O
made 13 17 757 761 O
for 18 21 762 765 O
patients 22 30 766 774 O
with 31 35 775 779 O
EGFR 36 40 780 784 B-clinical_variable
or 41 43 785 787 O
ALK 44 47 788 791 B-clinical_variable
re 48 50 792 794 O
- 50 51 794 795 O
arrangements 51 63 795 807 O
who 64 67 808 811 O
must 68 72 812 816 O
have 73 77 817 821 O
stopped 78 85 822 829 O
TKI 86 89 830 833 B-treatment
therapy 90 97 834 841 I-treatment
at 98 100 842 844 O
least 101 106 845 850 O
7 107 108 851 852 B-lower_bound
days 109 113 853 857 I-lower_bound
prior 114 119 858 863 I-lower_bound
to 120 122 864 866 O
C1D1 123 127 867 871 O

FFPE 0 4 872 876 O
material 5 13 877 885 O
for 14 17 886 889 O
ICH 18 21 890 893 B-chronic_disease
with 22 26 894 898 O
touch 27 32 899 904 O
prep 33 37 905 909 O
/ 37 38 909 910 O
representative 38 52 910 924 O
slide 53 58 925 930 O
confirming 59 69 931 941 O
tumor 70 75 942 947 B-cancer
material 76 84 948 956 O
present 85 92 957 964 O

For 0 3 965 968 O
those 4 9 969 974 O
who 10 13 975 978 O
have 14 18 979 983 O
received 19 27 984 992 O
prior 28 33 993 998 B-treatment
systemic 34 42 999 1007 I-treatment
anti 43 47 1008 1012 I-treatment
- 47 48 1012 1013 I-treatment
cancer 48 54 1013 1019 I-treatment
therapy 55 62 1020 1027 I-treatment
, 62 63 1027 1028 O
there 64 69 1029 1034 O
must 70 74 1035 1039 O
be 75 77 1040 1042 O
at 78 80 1043 1045 O
least 81 86 1046 1051 O
3 87 88 1052 1053 B-lower_bound
weeks 89 94 1054 1059 I-lower_bound
since 95 100 1060 1065 O
last 101 105 1066 1070 B-treatment
systemic 106 114 1071 1079 I-treatment
therapy 115 122 1080 1087 I-treatment

Have 0 4 1088 1092 O
a 5 6 1093 1094 O
safely 7 13 1095 1101 O
biopsiable 14 24 1102 1112 O
tumor 25 30 1113 1118 B-cancer
lesion 31 37 1119 1125 I-cancer

Have 0 4 1126 1130 O
collection 5 15 1131 1141 O
of 16 18 1142 1144 O
adequate 19 27 1145 1153 O
pre 28 31 1154 1157 B-treatment
- 31 32 1157 1158 I-treatment
treatment 32 41 1158 1167 I-treatment
tissue 42 48 1168 1174 O
for 49 52 1175 1178 O
correlative 53 64 1179 1190 O
analysis 65 73 1191 1199 O
defined 74 81 1200 1207 O
as 82 84 1208 1210 O
sufficient 85 95 1211 1221 O
material 96 104 1222 1230 O

Have 0 4 1231 1235 O
residual 5 13 1236 1244 B-cancer
disease 14 21 1245 1252 I-cancer
following 22 31 1253 1262 O
surgical 32 40 1263 1271 O
resection 41 50 1272 1281 O
that 51 55 1282 1286 O
is 56 58 1287 1289 O
measurable 59 69 1290 1300 O
by 70 72 1301 1303 O
RECIST 73 79 1304 1310 O
v1.1 80 84 1311 1315 O

Hemoglobin 0 10 1316 1326 B-clinical_variable
≥ 11 12 1327 1328 O
9.0 13 16 1329 1332 B-lower_bound
g 17 18 1333 1334 I-lower_bound
/ 18 19 1334 1335 I-lower_bound
dl 19 21 1335 1337 I-lower_bound

History 0 7 1338 1345 O
of 8 10 1346 1348 O
allergy 11 18 1349 1356 O
to 19 21 1357 1359 O
study 22 27 1360 1365 B-allergy_name
drug 28 32 1366 1370 I-allergy_name
components 33 43 1371 1381 O
or 44 46 1382 1384 O
history 47 54 1385 1392 O
of 55 57 1393 1395 O
severe 58 64 1396 1402 O
hypersensitivity 65 81 1403 1419 O
reaction 82 90 1420 1428 O
of 91 93 1429 1431 O
any 94 97 1432 1435 O
monoclonal 98 108 1436 1446 B-allergy_name
antibody 109 117 1447 1455 I-allergy_name

Inhaled 0 7 1456 1463 B-treatment
, 7 8 1463 1464 O
ocular 9 15 1465 1471 B-treatment
, 15 16 1471 1472 O
intra 17 22 1473 1478 B-treatment
- 22 23 1478 1479 I-treatment
articular 23 32 1479 1488 I-treatment
, 32 33 1488 1489 O
intranasal 34 44 1490 1500 B-treatment
, 44 45 1500 1501 O
and 46 49 1502 1505 O
topical 50 57 1506 1513 B-treatment
corticosteroids 58 73 1514 1529 I-treatment
are 74 77 1530 1533 O
permitted 78 87 1534 1543 O
in 88 90 1544 1546 O
absence 91 98 1547 1554 O
of 99 101 1555 1557 O
active 102 108 1558 1564 O
autoimmune 109 119 1565 1575 B-chronic_disease
disease 120 127 1576 1583 I-chronic_disease

Known 0 5 1584 1589 O
untreated 6 15 1590 1599 O
brain 16 21 1600 1605 O
or 22 24 1606 1608 O
leptomeningeal 25 39 1609 1623 B-cancer
metastasis 40 50 1624 1634 I-cancer

Maintenance 0 11 1635 1646 B-treatment
therapy 12 19 1647 1654 I-treatment
does 20 24 1655 1659 O
not 25 28 1660 1663 O
count 29 34 1664 1669 O
as 35 37 1670 1672 O
a 38 39 1673 1674 O
separate 40 48 1675 1683 O
line 49 53 1684 1688 O
of 54 56 1689 1691 O
therapy 57 64 1692 1699 O

Non 0 3 1700 1703 B-treatment
- 3 4 1703 1704 I-treatment
CNS 4 7 1704 1707 I-treatment
radiotherapy 8 20 1708 1720 I-treatment
within 21 27 1721 1727 O
1 28 29 1728 1729 B-upper_bound
week 30 34 1730 1734 I-upper_bound
prior 35 40 1735 1740 I-upper_bound
to 41 43 1741 1743 O
C1D1 44 48 1744 1748 O
of 49 51 1749 1751 O
study 52 57 1752 1757 B-treatment
therapy 58 65 1758 1765 I-treatment

Other 0 5 1766 1771 O
active 6 12 1772 1778 O
malignancy 13 23 1779 1789 B-cancer
requiring 24 33 1790 1799 O
concurrent 34 44 1800 1810 O
intervention 45 57 1811 1823 O

Patients 0 8 1824 1832 O
may 9 12 1833 1836 O
not 13 16 1837 1840 O
have 17 21 1841 1845 O
intervening 22 33 1846 1857 O
systemic 34 42 1858 1866 B-treatment
anti 43 47 1867 1871 I-treatment
- 47 48 1871 1872 I-treatment
cancer 48 54 1872 1878 I-treatment
therapy 55 62 1879 1886 I-treatment
between 63 70 1887 1894 O
the 71 74 1895 1898 O
time 75 79 1899 1903 O
of 80 82 1904 1906 O
resection 83 92 1907 1916 B-treatment
and 93 96 1917 1920 O
treatment 97 106 1921 1930 B-treatment
with 107 111 1931 1935 I-treatment
nivolumab 112 121 1936 1945 I-treatment

Patients 0 8 1946 1954 O
who 9 12 1955 1958 O
have 13 17 1959 1963 O
not 18 21 1964 1967 O
previously 22 32 1968 1978 O
been 33 37 1979 1983 O
treated 38 45 1984 1991 O
with 46 50 1992 1996 O
platinum 51 59 1997 2005 B-treatment
- 59 60 2005 2006 I-treatment
based 60 65 2006 2011 I-treatment
based 66 71 2012 2017 I-treatment
doublet 72 79 2018 2025 I-treatment
chemotherapy 80 92 2026 2038 I-treatment
and 93 96 2039 2042 O
who 97 100 2043 2046 O
, 100 101 2046 2047 O
in 102 104 2048 2050 O
the 105 108 2051 2054 O
judgment 109 117 2055 2063 O
of 118 120 2064 2066 O
the 121 124 2067 2070 O
investigator 125 137 2071 2083 O
, 137 138 2083 2084 O
have 139 143 2085 2089 O
rapidly 144 151 2090 2097 O
progressive 152 163 2098 2109 B-chronic_disease
disease 164 171 2110 2117 I-chronic_disease
such 172 176 2118 2122 O
that 177 181 2123 2127 O
serious 182 189 2128 2135 O
complications 190 203 2136 2149 O
may 204 207 2150 2153 O
arise 208 213 2154 2159 O
from 214 218 2160 2164 O
disease 219 226 2165 2172 O
progression 227 238 2173 2184 O
within 239 245 2185 2191 O
the 246 249 2192 2195 O
next 250 254 2196 2200 B-upper_bound
12 255 257 2201 2203 I-upper_bound
weeks 258 263 2204 2209 I-upper_bound

Patients 0 8 2210 2218 O
who 9 12 2219 2222 O
previously 13 23 2223 2233 O
received 24 32 2234 2242 O
neoadjuvant 33 44 2243 2254 B-treatment
, 44 45 2254 2255 O
concurrent 46 56 2256 2266 B-treatment
, 56 57 2266 2267 O
or 58 60 2268 2270 O
adjuvant 61 69 2271 2279 B-treatment
chemotherapy 70 82 2280 2292 I-treatment
for 83 86 2293 2296 O
localized 87 96 2297 2306 O
NSCLC 97 102 2307 2312 B-cancer
and 103 106 2313 2316 O
then 107 111 2317 2321 O
recurred 112 120 2322 2330 O
within 121 127 2331 2337 O
6 128 129 2338 2339 B-upper_bound
months 130 136 2340 2346 I-upper_bound
of 137 139 2347 2349 O
completing 140 150 2350 2360 O
chemotherapy 151 163 2361 2373 O
may 164 167 2374 2377 O
be 168 170 2378 2380 O
considered 171 181 2381 2391 O
as 182 184 2392 2394 O
having 185 191 2395 2401 O
received 192 200 2402 2410 O
one 201 204 2411 2414 O
line 205 209 2415 2419 O
of 210 212 2420 2422 O
prior 213 218 2423 2428 B-treatment
therapy 219 226 2429 2436 I-treatment

Patients 0 8 2437 2445 O
with 9 13 2446 2450 O
interstitial 14 26 2451 2463 B-chronic_disease
lung 27 31 2464 2468 I-chronic_disease
disease 32 39 2469 2476 I-chronic_disease
that 40 44 2477 2481 O
is 45 47 2482 2484 O
symptomatic 48 59 2485 2496 O
or 60 62 2497 2499 O
may 63 66 2500 2503 O
interfere 67 76 2504 2513 O
with 77 81 2514 2518 O
the 82 85 2519 2522 O
detection 86 95 2523 2532 O
or 96 98 2533 2535 O
management 99 109 2536 2546 O
of 110 112 2547 2549 O
suspected 113 122 2550 2559 O
drug 123 127 2560 2564 O
- 127 128 2564 2565 O
related 128 135 2565 2572 O
pulmonary 136 145 2573 2582 O
toxicity 146 154 2583 2591 O

Patients 0 8 2592 2600 O
with 9 13 2601 2605 O
known 14 19 2606 2611 O
or 20 22 2612 2614 O
suspected 23 32 2615 2624 O
history 33 40 2625 2632 O
of 41 43 2633 2635 O
autoimmune 44 54 2636 2646 B-chronic_disease
disease 55 62 2647 2654 I-chronic_disease

Platelet 0 8 2655 2663 B-clinical_variable
count 9 14 2664 2669 I-clinical_variable
≥ 15 16 2670 2671 O
100,000 17 24 2672 2679 B-lower_bound
/ 24 25 2679 2680 I-lower_bound
ul 25 27 2680 2682 I-lower_bound

Previously 0 10 2683 2693 O
treated 11 18 2694 2701 O
with 19 23 2702 2706 O
no 24 26 2707 2709 O
more 27 31 2710 2714 O
than 32 36 2715 2719 O
two 37 40 2720 2723 B-lower_bound
lines 41 46 2724 2729 O
of 47 49 2730 2732 O
prior 50 55 2733 2738 B-treatment
systemic 56 64 2739 2747 I-treatment
therapy 65 72 2748 2755 I-treatment
for 73 76 2756 2759 O
advanced 77 85 2760 2768 O
stage 86 91 2769 2774 O
lung 92 96 2775 2779 B-cancer
cancer 97 103 2780 2786 I-cancer

Prior 0 5 2787 2792 B-treatment
systemic 6 14 2793 2801 I-treatment
immunosuppressive 15 32 2802 2819 I-treatment
therapy 33 40 2820 2827 I-treatment
( 41 42 2828 2829 O
> 42 43 2829 2830 O
10 44 46 2831 2833 B-lower_bound
mg 47 49 2834 2836 I-lower_bound
/ 49 50 2836 2837 I-lower_bound
day 50 53 2837 2840 I-lower_bound
prednisone 54 64 2841 2851 B-treatment
equivalents 65 76 2852 2863 O
) 76 77 2863 2864 O
within 78 84 2865 2871 O
1 85 86 2872 2873 B-upper_bound
week 87 91 2874 2878 I-upper_bound
prior 92 97 2879 2884 I-upper_bound
to 98 100 2885 2887 O
C1D1 101 105 2888 2892 B-clinical_variable
of 106 108 2893 2895 O
study 109 114 2896 2901 B-treatment
therapy 115 122 2902 2909 I-treatment

Prior 0 5 2910 2915 B-treatment
treatment 6 15 2916 2925 I-treatment
with 16 20 2926 2930 O
immune 21 27 2931 2937 O
checkpoint 28 38 2938 2948 B-treatment
inhibitor 39 48 2949 2958 I-treatment
, 48 49 2958 2959 O
including 50 59 2960 2969 O
( 60 61 2970 2971 O
but 61 64 2971 2974 O
not 65 68 2975 2978 O
limited 69 76 2979 2986 O
to 77 79 2987 2989 O
) 79 80 2989 2990 O
those 81 86 2991 2996 O
targeting 87 96 2997 3006 O
PD-1 97 101 3007 3011 O
, 101 102 3011 3012 O
PD 103 105 3013 3015 O
- 105 106 3015 3016 O
L1 106 108 3016 3018 O
, 108 109 3018 3019 O
PD 110 112 3020 3022 O
- 112 113 3022 3023 O
L2 113 115 3023 3025 O
, 115 116 3025 3026 O
CTLA-4 117 123 3027 3033 O
, 123 124 3033 3034 O
CD137 125 130 3035 3040 O
, 130 131 3040 3041 O
GITR 132 136 3042 3046 O
, 136 137 3046 3047 O
TIM3 138 142 3048 3052 O
, 142 143 3052 3053 O
LAG3 144 148 3054 3058 O
, 148 149 3058 3059 O
or 150 152 3060 3062 O
OX40 153 157 3063 3067 O

Subjects 0 8 3068 3076 O
with 9 13 3077 3081 O
type 14 18 3082 3086 B-chronic_disease
I 19 20 3087 3088 I-chronic_disease
diabetes 21 29 3089 3097 I-chronic_disease
melitis 30 37 3098 3105 I-chronic_disease
, 37 38 3105 3106 O
hypothyroidism 39 53 3107 3121 B-chronic_disease
only 54 58 3122 3126 O
requiring 59 68 3127 3136 O
hormone 69 76 3137 3144 B-treatment
replacement 77 88 3145 3156 I-treatment
, 88 89 3156 3157 O
resolved 90 98 3158 3166 O
childhood 99 108 3167 3176 O
asthma 109 115 3177 3183 B-chronic_disease
/ 115 116 3183 3184 O
atopy 116 121 3184 3189 B-chronic_disease
, 121 122 3189 3190 O
patients 123 131 3191 3199 O
with 132 136 3200 3204 O
asthma 137 143 3205 3211 O
requiring 144 153 3212 3221 O
intermittent 154 166 3222 3234 B-treatment
bronchodilator 167 181 3235 3249 I-treatment
therapy 182 189 3250 3257 I-treatment
, 189 190 3257 3258 O
skin 191 195 3259 3263 B-chronic_disease
disorders 196 205 3264 3273 I-chronic_disease
( 206 207 3274 3275 O
such 207 211 3275 3279 O
as 212 214 3280 3282 O
vitiligo 215 223 3283 3291 B-chronic_disease
, 223 224 3291 3292 O
psoriasis 225 234 3293 3302 B-chronic_disease
, 234 235 3302 3303 O
or 236 238 3304 3306 O
alopecia 239 247 3307 3315 B-chronic_disease
) 247 248 3315 3316 O
not 249 252 3317 3320 O
requiring 253 262 3321 3330 O
systemic 263 271 3331 3339 B-treatment
treatment 272 281 3340 3349 I-treatment
, 281 282 3349 3350 O
or 283 285 3351 3353 O
conditions 286 296 3354 3364 O
not 297 300 3365 3368 O
expected 301 309 3369 3377 O
to 310 312 3378 3380 O
recur 313 318 3381 3386 O
in 319 321 3387 3389 O
the 322 325 3390 3393 O
absence 326 333 3394 3401 O
of 334 336 3402 3404 O
an 337 339 3405 3407 O
external 340 348 3408 3416 O
trigger 349 356 3417 3424 O

There 0 5 3425 3430 O
is 6 8 3431 3433 O
no 9 11 3434 3436 O
restriction 12 23 3437 3448 O
on 24 26 3449 3451 O
the 27 30 3452 3455 O
number 31 37 3456 3462 O
of 38 40 3463 3465 O
prior 41 46 3466 3471 O
lines 47 52 3472 3477 O
of 53 55 3478 3480 O
systemic 56 64 3481 3489 B-treatment
anti 65 69 3490 3494 I-treatment
- 69 70 3494 3495 I-treatment
cancer 70 76 3495 3501 I-treatment
therapy 77 84 3502 3509 I-treatment

WBC 0 3 3510 3513 B-clinical_variable
≥ 4 5 3514 3515 O
2,000 6 11 3516 3521 B-lower_bound
/ 11 12 3521 3522 I-lower_bound
ul 12 14 3522 3524 I-lower_bound

Women 0 5 3525 3530 B-gender
of 6 8 3531 3533 O
childbearing 9 21 3534 3546 O
potential 22 31 3547 3556 O
( 32 33 3557 3558 O
WOCBP 33 38 3558 3563 O
) 38 39 3563 3564 O
must 40 44 3565 3569 O
have 45 49 3570 3574 O
a 50 51 3575 3576 O
negative 52 60 3577 3585 B-pregnancy
serum 61 66 3586 3591 I-pregnancy
or 67 69 3592 3594 I-pregnancy
urine 70 75 3595 3600 I-pregnancy
pregnancy 76 85 3601 3610 I-pregnancy
test 86 90 3611 3615 O
( 91 92 3616 3617 O
minimum 92 99 3617 3624 O
sensitivity 100 111 3625 3636 O
25 112 114 3637 3639 B-lower_bound
IU 115 117 3640 3642 I-lower_bound
/ 117 118 3642 3643 I-lower_bound
L 118 119 3643 3644 I-lower_bound
or 120 122 3645 3647 O
equivalent 123 133 3648 3658 O
units 134 139 3659 3664 O
of 140 142 3665 3667 O
HCG 143 146 3668 3671 B-clinical_variable
) 146 147 3671 3672 O
within 148 154 3673 3679 O
3 155 156 3680 3681 B-upper_bound
days 157 161 3682 3686 I-upper_bound
prior 162 167 3687 3692 I-upper_bound
to 168 170 3693 3695 O
the 171 174 3696 3699 O
start 175 180 3700 3705 O
of 181 183 3706 3708 O
study 184 189 3709 3714 B-treatment
drug 190 194 3715 3719 I-treatment

Women 0 5 3720 3725 B-gender
of 6 8 3726 3728 O
childbearing 9 21 3729 3741 O
potential 22 31 3742 3751 O
must 32 36 3752 3756 O
agree 37 42 3757 3762 B-contraception_consent
to 43 45 3763 3765 I-contraception_consent
practice 46 54 3766 3774 I-contraception_consent
2 55 56 3775 3776 I-contraception_consent
effective 57 66 3777 3786 I-contraception_consent
methods 67 74 3787 3794 I-contraception_consent
of 75 77 3795 3797 I-contraception_consent
contraception 78 91 3798 3811 I-contraception_consent
from 92 96 3812 3816 O
the 97 100 3817 3820 O
time 101 105 3821 3825 O
of 106 108 3826 3828 O
signing 109 116 3829 3836 O
the 117 120 3837 3840 O
informed 121 129 3841 3849 O
consent 130 137 3850 3857 O
form 138 142 3858 3862 O
through 143 150 3863 3870 O
23 151 153 3871 3873 B-upper_bound
weeks 154 159 3874 3879 I-upper_bound
( 160 161 3880 3881 O
5 161 162 3881 3882 B-upper_bound
half 163 167 3883 3887 O
- 167 168 3887 3888 O
lifes 168 173 3888 3893 O
plus 174 178 3894 3898 O
30 179 181 3899 3901 O
days 182 186 3902 3906 O
, 186 187 3906 3907 O
the 188 191 3908 3911 O
duration 192 200 3912 3920 O
of 201 203 3921 3923 O
an 204 206 3924 3926 O
ovulatory 207 216 3927 3936 O
cycle 217 222 3937 3942 O
) 222 223 3942 3943 O
after 224 229 3944 3949 O
the 230 233 3950 3953 O
last 234 238 3954 3958 O
dose 239 243 3959 3963 O
of 244 246 3964 3966 O
nivolumab 247 256 3967 3976 B-treatment
, 256 257 3976 3977 O
or 258 260 3978 3980 O
agree 261 266 3981 3986 B-contraception_consent
to 267 269 3987 3989 I-contraception_consent
completely 270 280 3990 4000 I-contraception_consent
abstain 281 288 4001 4008 I-contraception_consent
from 289 293 4009 4013 I-contraception_consent
heterosexual 294 306 4014 4026 I-contraception_consent
intercourse 307 318 4027 4038 I-contraception_consent

frozen 0 6 4039 4045 O
tissue 7 13 4046 4052 O
for 14 17 4053 4056 O
DNA 18 21 4057 4060 O
/ 21 22 4060 4061 O
RNA 22 25 4061 4064 O
with 26 30 4065 4069 O
touch 31 36 4070 4075 O
prep 37 41 4076 4080 O
/ 41 42 4080 4081 O
representative 42 56 4081 4095 O
slide 57 62 4096 4101 O
confirming 63 73 4102 4112 O
tumor 74 79 4113 4118 B-cancer
material 80 88 4119 4127 O
present 89 96 4128 4135 O

no 0 2 4136 4138 O
requirement 3 14 4139 4150 O
for 15 18 4151 4154 O
immunosuppressive 19 36 4155 4172 B-treatment
doses 37 42 4173 4178 I-treatment
of 43 45 4179 4181 I-treatment
systemic 46 54 4182 4190 I-treatment
corticosteroids 55 70 4191 4206 I-treatment
( 71 72 4207 4208 O
> 72 73 4208 4209 O
10 74 76 4210 4212 B-lower_bound
mg 77 79 4213 4215 I-lower_bound
/ 79 80 4215 4216 I-lower_bound
day 80 83 4216 4219 I-lower_bound
prednisone 84 94 4220 4230 B-treatment
equivalents 95 106 4231 4242 O
) 106 107 4242 4243 O
for 108 111 4244 4247 O
at 112 114 4248 4250 O
least 115 120 4251 4256 O
2 121 122 4257 4258 B-upper_bound
weeks 123 128 4259 4264 I-upper_bound
prior 129 134 4265 4270 I-upper_bound
to 135 137 4271 4273 O
study 138 143 4274 4279 B-treatment
drug 144 148 4280 4284 I-treatment
administration 149 163 4285 4299 O

practice 0 8 4300 4308 O
effective 9 18 4309 4318 O
barrier 19 26 4319 4326 B-contraception_consent
contraception 27 40 4327 4340 I-contraception_consent
during 41 47 4341 4347 O
the 48 51 4348 4351 O
entire 52 58 4352 4358 O
study 59 64 4359 4364 B-treatment
treatment 65 74 4365 4374 I-treatment
period 75 81 4375 4381 O
and 82 85 4382 4385 O
through 86 93 4386 4393 O
31 94 96 4394 4396 B-upper_bound
weeks 97 102 4397 4402 I-upper_bound
( 103 104 4403 4404 O
5 104 105 4404 4405 O
half 106 110 4406 4410 O
- 110 111 4410 4411 O
lives 111 116 4411 4416 O
plus 117 121 4417 4421 O
90 122 124 4422 4424 O
days 125 129 4425 4429 O
, 129 130 4429 4430 O
the 131 134 4431 4434 O
duration 135 143 4435 4443 O
of 144 146 4444 4446 O
sperm 147 152 4447 4452 O
turnover 153 161 4453 4461 O
) 161 162 4461 4462 O
after 163 168 4463 4468 O
the 169 172 4469 4472 O
last 173 177 4473 4477 O
dose 178 182 4478 4482 O
of 183 185 4483 4485 O
study 186 191 4486 4491 B-treatment
drug 192 196 4492 4496 I-treatment
, 196 197 4496 4497 O
or 198 200 4498 4500 O
completely 201 211 4501 4511 O
abstain 212 219 4512 4519 O
from 220 224 4520 4524 O
heterosexual 225 237 4525 4537 O
intercourse 238 249 4538 4549 O

pregnant 0 8 4550 4558 B-pregnancy

single 0 6 4559 4565 B-clinical_variable
- 6 7 4565 4566 I-clinical_variable
cell 7 11 4566 4570 I-clinical_variable
suspensions 12 23 4571 4582 I-clinical_variable
with 24 28 4583 4587 O
> 29 30 4588 4589 O
20 30 32 4589 4591 B-lower_bound
million 33 40 4592 4599 O
live 41 45 4600 4604 O
cells 46 51 4605 4610 O
after 52 57 4611 4616 O
tissue 58 64 4617 4623 O
digestion 65 74 4624 4633 O
but 75 78 4634 4637 O
before 79 85 4638 4644 O
freezing 86 94 4645 4653 O

≥ 0 1 4654 4655 O
18 2 4 4656 4658 B-lower_bound
years 5 10 4659 4664 I-lower_bound
old 11 14 4665 4668 O

